Wellington Management Group LLP Sells 998 Shares of Chemed Co. (NYSE:CHE)

Wellington Management Group LLP lessened its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 30.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,244 shares of the company's stock after selling 998 shares during the quarter. Wellington Management Group LLP's holdings in Chemed were worth $1,189,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of CHE. Wealth Enhancement Advisory Services LLC increased its position in Chemed by 17.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 1,382 shares of the company's stock worth $732,000 after buying an additional 207 shares in the last quarter. Centaurus Financial Inc. increased its position in Chemed by 5.6% in the fourth quarter. Centaurus Financial Inc. now owns 5,354 shares of the company's stock worth $2,837,000 after buying an additional 283 shares in the last quarter. Cim LLC increased its position in Chemed by 2.2% in the fourth quarter. Cim LLC now owns 2,008 shares of the company's stock worth $1,064,000 after buying an additional 44 shares in the last quarter. Jefferies Financial Group Inc. increased its position in Chemed by 335.0% in the fourth quarter. Jefferies Financial Group Inc. now owns 1,453 shares of the company's stock worth $770,000 after buying an additional 1,119 shares in the last quarter. Finally, United Advisor Group LLC increased its position in Chemed by 25.1% in the fourth quarter. United Advisor Group LLC now owns 807 shares of the company's stock worth $428,000 after buying an additional 162 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Insider Transactions at Chemed

In other news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total value of $866,790.00. Following the completion of the transaction, the executive vice president now owns 16,127 shares of the company's stock, valued at $9,319,148.22. This represents a 8.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This trade represents a 0.97% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,500 shares of company stock valued at $3,213,780 over the last 90 days. Company insiders own 3.29% of the company's stock.

Analysts Set New Price Targets

CHE has been the subject of a number of analyst reports. Royal Bank of Canada upped their price target on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Wall Street Zen upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.

Chemed Stock Up 0.2%

CHE traded up $1.06 during midday trading on Friday, reaching $561.84. The company had a trading volume of 79,703 shares, compared to its average volume of 103,174. The company has a market cap of $8.22 billion, a P/E ratio of 28.39, a P/E/G ratio of 2.15 and a beta of 0.54. The business has a 50-day moving average of $575.83 and a two-hundred day moving average of $566.08. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $5.20 earnings per share. On average, equities research analysts predict that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's dividend payout ratio (DPR) is 9.74%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.